SITE MAP | CONTACT Our company | Research and development | Social responsibility | Our drugs | Career Social responsibility Bristol-Myers Squibb Foundation Cooperation with Patient Organizations Transparency Home » Social responsibility » Transparency EFPIA TRANSPARENCY CODE The Disclosure Code of the European Federation of Pharmaceutical Industries and Associations (EFPIA) has been approved, which means that member associations are required to adopt transparency provisions and incorporate them into national codes of conduct before December 21, 2013. The EFPIA Disclosure Code provides guidelines for members regarding the disclosure of certain payments or other benefits made to healthcare professionals and healthcare organizations. Examples of public transactions include, but are not limited to, a grant to a healthcare organization or compensation to a healthcare professional for public speaking. As a member of EFPIA, we fully endorse its Transparency Code for the disclosure of payments or other benefits provided by pharmaceutical companies to healthcare professionals and healthcare organizations. Pursuant to the provisions of the Code, at the beginning of 2016, we will begin to publicize payments made to healthcare professionals practicing in Europe and to healthcare organizations based in Europe. We hope that this will contribute to a better understanding of the cooperation between our industry and the medical community and, consequently, will lead to building a belief that it is fully justified. The most frequently asked questions about the EFPIA Disclosure Code Code of Good Practices in the Pharmaceutical Industry Why do we work with representatives of medical professions: Why we make public payments to healthcare professionals: Methodologies for what we make public: EFPIA publication report: For any questions regarding transactions made public by Bristol-Myers Squibb, please contact us at: BMS Transparency Hotline: 00-800-1215535 Or send an inquiry to : mg-transparency_bms@bms.com Legal notice | Privacy Policy | Reporting side effects © 2014 Bristol-Myers Squibb. All rights reserved. This website contains information intended for people living in Poland.

SITE MAP | CONTACT Our company | Research and development | Social responsibility | Our drugs | Career Research and development Therapeutic areas Oncology Virology Immunology Cardiology Clinical tests Home » Research and Development » Therapeutic areas Therapeutic areas Bristol-Myers Squibb's mission is to discover, develop and deliver innovative drugs to help patients overcome serious diseases. We focus on four main therapeutic areas: Oncology Virology Immunology Cardiology Legal notice | Privacy Policy | Reporting side effects © 2014 Bristol-Myers Squibb. All rights reserved. This website contains information intended for people living in Poland.